Old agent, new experience: Colistin use in the paediatric Intensive Care Unit - A multicentre study

International Journal of Antimicrobial Agents

Volumn 40, Issue 2, 2012, Pages 140-144

  Paksu, Muhammet Sukru ^a   Paksu, Sule ^a   Karadag, Adil ^a   Sensoy, Gülnar ^a   Asilioglu, Nazik ^a   Yildizdas, Dincer ^b   Akyildiz, Basak Nur ^c   Kendirli, Tanil ^d   Demirkol, Demet ^e   Akgun, Muhammet ^a   Alp, Emine ^c   Ciftci, Ergin ^d   Guney, Akif Koray ^a   Murat, Naci ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^b CUKUROVA UNIVERSITY   (Turkey)

^c ERCIYES UNIVERSITY   (Turkey)

^d ANKARA UNIVERSITY   (Turkey)

^e ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Child; Colistin; Multidrug resistant; Nosocomial infection; Paediatric Intensive Care Unit

Indexed keywords

COLISTIN;

ACINETOBACTER BAUMANNII; ADOLESCENT; ADULT; APNEA; ARTICLE; CHILD; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; GRAM NEGATIVE BACTERIUM; HOSPITAL INFECTION; HUMAN; INFANT; INTENSIVE CARE UNIT; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY (TOPIC); MULTIDRUG RESISTANCE; MUSCLE WEAKNESS; NEPHROTOXICITY; NEUROMUSCULAR BLOCKING; NONHUMAN; PARESTHESIA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; SEIZURE; SIDE EFFECT; TONIC CLONIC SEIZURE; TREATMENT DURATION; TREATMENT OUTCOME; VENTILATOR ASSOCIATED PNEUMONIA; VERTIGO;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADOLESCENT; CHILD; CHILD, PRESCHOOL; COLISTIN; CROSS INFECTION; DRUG ADMINISTRATION SCHEDULE; DRUG EVALUATION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; INFANT; INTENSIVE CARE UNITS, PEDIATRIC; MALE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; SEIZURES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84864278146     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2012.04.010     Document Type: Article

References (34)

1. M.E. Falagas, and D.E. Karageorgopoulos Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology Clin Infect Dis 46 2008 1121 1122 author reply 1122
2. J. Goverman, J.M. Weber, T.J. Keaney, and R.L. Sheridan Intravenous colistin for the treatment of multi-drug resistant, Gram-negative infection in the pediatric burn population J Burn Care Res 28 2007 421 426
3. M. Souli, I. Galani, and H. Giamarellou Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe Euro Surveill 13 2008 pii: 19045
4. H.W. Boucher, G.H. Talbot, J.S. Bradley, J.E. Edwards, D. Gilbert, and L.B. Rice Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America Clin Infect Dis 48 2009 1 12
5. S. Celebi, M. Hacimustafaoglu, N. Koksal, H. Ozkan, and M. Cetinkaya Colistimethate sodium therapy for multidrug-resistant isolates in pediatric patients Pediatr Int 52 2010 410 414
6. M.E. Falagas, E.K. Vouloumanou, and P.I. Rafailidis Systemic colistin use in children without cystic fibrosis: a systematic review of the literature Int J Antimicrob Agents 33 2009 503.e1 503.e13
7. S. Ramasubban, A. Majumdar, and P.S. Das Safety and efficacy of polymyxin B in multidrug resistant Gram-negative severe sepsis and septic shock Indian J Crit Care Med 12 2008 153 157
8. C.Y. Cheng, W.H. Sheng, J.T. Wang, Y.C. Chen, and S.C. Chang Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections Int J Antimicrob Agents 35 2010 297 300
9. N. Durakovic, V. Radojcic, A. Boban, M. Mrsic, D. Sertic, and R. Serventi-Seiwerth Efficacy and safety of colistin in the treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in patients with hematologic malignancy: a matched pair analysis Intern Med 50 2011 1009 1013
10. E. Iosifidis, C. Antachopoulos, M. Ioannidou, M. Mitroudi, M. Sdougka, and V. Drossou-Agakidou Colistin administration to pediatric and neonatal patients Eur J Pediatr 169 2010 867 874
11. J.S. Garner, W.R. Jarvis, T.G. Emori, T.C. Horan, and J.M. Hughes CDC definitions for nosocomial infections, 1988 Am J Infect Control 16 1988 128 140
12. B. Goldstein, B. Giroir, A. Randolph International Consensus Conference on Pediatric Sepsis International Pediatric Sepsis Consensus Conference: definitions for sepsis and organ dysfunction in pediatrics Pediatr Crit Care Med 6 2005 2 8
13. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing; twenty-first informational supplement. Document M100-S21 2011 CLSI Wayne, PA
14. M.E. Falagas, and S.K. Kasiakou Colistin: the revival of polymyxins for the management of multidrug-resistant Gram-negative bacterial infections Clin Infect Dis 40 2005 1333 1341
15. M. Jajoo, V. Kumar, M. Jain, S. Kumari, and V. Manchanda Intravenous colistin administration in neonates Pediatr Infect Dis J 30 2011 218 221
16. M. Rosanova, C. Epelbaum, A. Noman, M. Villasboas, V. Alvarez, and G. Berberian Use of colistin in a pediatric burn unit in Argentina J Burn Care Res 30 2009 612 615
17. M.E. Falagas, G. Sideri, E.K. Vouloumanou, J.H. Papadatos, and D.A. Kafetzis Intravenous colistimethate (colistin) use in critically ill children without cystic fibrosis Pediatr Infect Dis J 28 2009 123 127
18. A.S. Levin, A.A. Barone, J. Penco, M.V. Santos, I.S. Marinho, and E.A. Arruda Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii Clin Infect Dis 28 1999 1008 1011
19. J. Garnacho-Montero, C. Ortiz-Leyba, F.J. Jiménez-Jiménez, A.E. Barrero-Almodóvar, J.L. García-Garmendia, and I.M. Bernabeu-Wittel Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP Clin Infect Dis 36 2003 1111 1118
20. S. Gupta, D. Govil, P.N. Kakar, O. Prakash, D. Arora, and S. Das Colistin and polymyxin B: a re-emergence Indian J Crit Care Med 13 2009 49 53
21. D. Landman, C. Georgescu, D.A. Martin, and J. Quale Polymyxins revisited Clin Microbiol Rev 21 2008 449 465
22. N. Petrosillo, E. Ioannidou, and M.E. Falagas Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies Clin Microbiol Infect 14 2008 816 827
23. T.T. Yoshikawa, A.S. Bayer, and L.B. Guze Endocarditis due to Pseudomonas aeruginosa in a heroin addict. Successful treatment with trimethoprim- sulfamethoxazole mixture plus colistin Chest 72 1977 794 796
24. F. Timurkaynak, F. Can, O.K. Azap, M. Demirbilek, H. Arslan, and S.O. Karaman In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units Int J Antimicrob Agents 27 2006 224 228
25. M.E. Falagas, P.I. Rafailidis, S.K. Kasiakou, P. Hatzopoulou, and A. Michalopoulos Effectiveness and nephrotoxicity of colistin monotherapy vs. colistin-meropenem combination therapy for multidrug-resistant Gram-negative bacterial infections Clin Microbiol Infect 12 2006 1227 1230
26. P.K. Linden, S. Kusne, K. Coley, P. Fontes, D.J. Kramer, and D. Paterson Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa Clin Infect Dis 37 2003 e154 e160
27. C. Antachopoulos, M. Karvanen, E. Iosifidis, B. Jansson, D. Plachouras, and O. Cars Serum and cerebrospinal fluid levels of colistin in pediatric patients Antimicrob Agents Chemother 54 2010 3985 3987
28. M.E. Jiménez-Mejías, C. Pichardo-Guerrero, F.J. Márquez-Rivas, D. Martín-Lozano, T. Prados, and J. Pachón Cerebrospinal fluid penetration and pharmacokinetic/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis Eur J Clin Microbiol Infect Dis 21 2002 212 214
29. P.D. Tamma, and C.K. Lee Use of colistin in children Pediatr Infect Dis J 28 2009 534 535
30. J. Koch-Weser, V.W. Sidel, E.B. Federman, P. Kanarek, D.C. Finer, and A.E. Eaton Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy Ann Intern Med 72 1970 857 868
31. M.E. Falagas, K.N. Fragoulis, S.K. Kasiakou, G.J. Sermaidis, and A. Michalopoulos Nephrotoxicity of intravenous colistin: a prospective evaluation Int J Antimicrob Agents 26 2005 504 507
32. M.D. Reed, R.C. Stern, M.A. O'Riordan, and J.L. Blumer The pharmacokinetics of colistin in patients with cystic fibrosis J Clin Pharmacol 41 2001 645 654
33. J. Li, R.L. Nation, J.D. Turnidge, R.W. Milne, K. Coulthard, and C.R. Rayner Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections Lancet Infect Dis 6 2006 589 601
34. V. Pintado, L.G. San Miguel, F. Grill, B. Mejia, J. Cobo, and J. Fortun Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant Gram-negative bacteria J Infect 56 2008 185 190